GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Vytrus Biotech SA (XMAD:VYT) » Definitions » ROE % Adjusted to Book Value

Vytrus Biotech (XMAD:VYT) ROE % Adjusted to Book Value : 6.21% (As of Jun. 2024)


View and export this data going back to 2022. Start your Free Trial

What is Vytrus Biotech ROE % Adjusted to Book Value?

Vytrus Biotech's ROE % for the quarter that ended in Jun. 2024 was 16.89%. Vytrus Biotech's PB Ratio for the quarter that ended in Jun. 2024 was 2.72. Vytrus Biotech's ROE % Adjusted to Book Value for the quarter that ended in Jun. 2024 was 6.21%.

Vytrus Biotech ROE % Adjusted to Book Value Historical Data

The historical data trend for Vytrus Biotech's ROE % Adjusted to Book Value can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Vytrus Biotech ROE % Adjusted to Book Value Chart

Vytrus Biotech Annual Data
Trend Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
ROE % Adjusted to Book Value
Get a 7-Day Free Trial - - - 2.74 4.58

Vytrus Biotech Semi-Annual Data
Dec18 Dec19 Dec20 Jun21 Dec21 Jun22 Dec22 Jun23 Dec23 Jun24
ROE % Adjusted to Book Value Get a 7-Day Free Trial Premium Member Only Premium Member Only 3.16 2.35 3.94 3.04 6.21

Competitive Comparison of Vytrus Biotech's ROE % Adjusted to Book Value

For the Biotechnology subindustry, Vytrus Biotech's ROE % Adjusted to Book Value, along with its competitors' market caps and ROE % Adjusted to Book Value data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Vytrus Biotech's ROE % Adjusted to Book Value Distribution in the Biotechnology Industry

For the Biotechnology industry and Healthcare sector, Vytrus Biotech's ROE % Adjusted to Book Value distribution charts can be found below:

* The bar in red indicates where Vytrus Biotech's ROE % Adjusted to Book Value falls into.


;
;

Vytrus Biotech ROE % Adjusted to Book Value Calculation

Vytrus Biotech's ROE % Adjusted to Book Value for the fiscal year that ended in Dec. 2023 is calculated as

ROE % Adjusted to Book Value=ROE % / PB Ratio
=10.85% / 2.37
=4.58%

Vytrus Biotech's ROE % Adjusted to Book Value for the quarter that ended in Jun. 2024 is calculated as

ROE % Adjusted to Book Value=ROE % / PB Ratio
=16.89% / 2.72
=6.21%

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Vytrus Biotech ROE % Adjusted to Book Value Related Terms

Thank you for viewing the detailed overview of Vytrus Biotech's ROE % Adjusted to Book Value provided by GuruFocus.com. Please click on the following links to see related term pages.

Vytrus Biotech Business Description

Industry
GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Vytrus Biotech SA (XMAD:VYT) » Definitions » ROE % Adjusted to Book Value
Comparable Companies
XMAD:BST VRTX ASX:CSL REGN XKRX:207940 XBRU:ARGX ALNY XBRU:UCB ONC XKRX:068270 BNTX SMMT INSM HKSE:02269 BMRN RPRX XKRX:196170 OCSE:GMAB MRNA INCY
Traded in Other Exchanges
N/A
Address
Sant Gaieta 121, 2nd, Terrassa, Barcelona, ESP, 08221
Website
https://www.vytrus.com
Vytrus Biotech SA develops natural active ingredients on an industrial scale. The natural actives offered by the company include Nectaria Lithops, Olea Vitae, Turmeric zen, Capilia Longa, Qura Noni.

Vytrus Biotech Headlines

No Headlines